BioMarin’s (BMRN) Phase 3 Trial of BMN 401 for ENPP1 Deficiency Meets One Co-Primary Endpoint

She Didn’t Want to Sell the Farm. Selling the Development Rights Instead Could Still Cost Her on Social Security and Medicare.

Arizona State launches degree on becoming an influencer — exactly the career more than half of Gen Z adults dream of

AT&T CEO explains why AT&T can withstand satellite competition

Better Healthcare Sector ETF: Vanguard's Broad VHT vs. Invesco's Biotechnology-Focused IBBQ

Down 40% on the Year, Is ServiceNow Stock a Buy as Its Subscription Revenue Surges 25%?

1 Top Warren Buffett Stock for Dividend Investors